StockData
Amneal Pharmaceuticals, Inc. logo

Amneal Pharmaceuticals, Inc. (AMRX) stock

AMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3063% above fair value
$21.88+0.76 (+3.60%)

Close on Nov 18, 2026Market cap $6.99BP/E 44.7Yield –

Amneal Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Amneal Pharmaceuticals's pe ratio was 44.3× on Nov 11, 2026, against 626.0× a year earlier. Over the last 3 years it ranged from 8.8× to 956.0×, with a median of 56.5×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202644.3×−585.7
2025Dec 31, 2025630.0×+540.8
2024Jan 31, 202489.2×−12.0
2023Dec 29, 2023101.2×−75.8
2022Jul 29, 2022177.0×+123.8
2021Dec 31, 202153.2×+42.1
2020Dec 31, 202011.1×–

More Amneal Pharmaceuticals figures

See a number that looks wrong?